CELC · Celcuity Inc.
Market Cap
$4.36B
Shares
48.93M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$177.04M
-58.4%
FY2025
Diluted EPS
-$3.79
-33.9%
FY2025
Operating Cash Flow
-$153.28M
-83.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $142.96M | $145M | $104.2M | $60.59M | $35.29M | $25.76M | $7.68M | $6.27M | $6.33M | $4.98M | $3.06M | |
| — | $27.2M | $9.06M | $5.64M | $4.1M | $2.6M | $1.87M | $1.54M | $1.61M | $972.52K | $263.66K | |
| $208.68M | $172.19M | $113.27M | $66.23M | $39.39M | $28.36M | $9.56M | $7.81M | $7.93M | $5.95M | $3.33M | |
| -$208.68M | -$172.19M | -$113.27M | -$66.23M | -$39.39M | -$28.36M | -$9.56M | -$7.81M | -$7.93M | -$5.95M | -$3.33M | |
| $22.27M | $17.15M | $10.28M | $5.33M | $2.11M | $1.26M | $120 | $159 | $111 | $451.66K | $0 | |
| $15.94M | $12.3M | $11.77M | $7.78M | $1.13M | $13.26K | $82.11K | $446.1K | $448.83K | $152.88K | $18.02K | |
| -$17.81M | -$4.85M | $1.49M | $2.45M | -$978.95K | -$1.25M | $81.99K | $445.94K | $451.72K | -$298.79K | $18.02K | |
| -$226.48M | -$177.04M | -$111.78M | -$63.78M | -$40.37M | -$29.61M | -$9.47M | -$7.36M | -$7.48M | -$6.25M | -$3.31M | |
| $0 | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| -$226.48M | -$177.04M | -$111.78M | -$63.78M | -$40.37M | -$29.61M | -$9.47M | -$7.36M | -$7.48M | -$6.25M | -$3.31M | |
| USD/shares | -$4.30 | -$3.79 | -$2.83 | -$2.69 | -$2.64 | -$2.21 | — | — | — | — | — |
| USD/shares | -$4.30 | -$3.79 | -$2.83 | -$2.69 | -$2.64 | — | — | — | — | — | — |
| shares | — | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M | 10.27M | 10.23M | 10.12M | 7.46M | 6.31M |
| shares | — | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M | 10.27M | 10.23M | 10.12M | 7.46M | 6.31M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 6.29×
EV/EBIT
—
Peer median 23.84×
P/E (TTM)
—
Peer median 18.83×
Peer medians compare against the 197 similar-size Biotechnology companies (of 497 listed).
Key facts
CIK
1603454
CUSIP
15102K100
13F (30d)
238 filings
237 filers
Visit website
Investor relations